Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1983-2-14
|
pubmed:abstractText |
Plasmapheresis has been used as a supplementary method for the treatment of 11 cases of SLE (7 with lupus nephritis and 4 without renal changes). In 7 cases there was a marked improvement during the plasma exchanges which lasted from 2 months to 3 years of follow up. In one case the direct result was satisfactory but after 3 months there was a severe relapse and the patient died. In 3 cases (two without lupus nephritis) plasmapheresis was without any effect. We believe that plasmapheresis is chiefly indicated in severe cases with high levels of ds-DNA antibody titers.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0004-069X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
769-72
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:6983871-Adolescent,
pubmed-meshheading:6983871-Adult,
pubmed-meshheading:6983871-Antibodies, Antinuclear,
pubmed-meshheading:6983871-Antigen-Antibody Complex,
pubmed-meshheading:6983871-Female,
pubmed-meshheading:6983871-Humans,
pubmed-meshheading:6983871-Kidney Diseases,
pubmed-meshheading:6983871-Lupus Erythematosus, Systemic,
pubmed-meshheading:6983871-Male,
pubmed-meshheading:6983871-Plasmapheresis
|
pubmed:year |
1981
|
pubmed:articleTitle |
Plasmapheresis in the treatment of systemic lupus erythematosus.
|
pubmed:publicationType |
Journal Article,
Case Reports
|